D-serine zwitterion: all 25 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease ProgressionRecruitingNCT07312110Phase 2
- Cognitive Strategies in Early Psychosis 2RecruitingNCT07263022Phase 3
- Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersRecruitingNCT07079930Phase 1
- Pharmacologic Augmentation of TMS for Depression With D-serineRecruitingNCT06876129Phase 1
- D-serine Augmentation of NeuroplasticityCompletedNCT03711500Phase 1/2Results posted
- D-serine and Cognitive Remediation in SchizophreniaCompletedNCT02156908Phase 2Results posted
- Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic NeurotransmissionCompletedNCT01018056Phase 4Results posted
- D-serine for the Schizophrenia ProdromeCompletedNCT00826202Phase 2Results posted
- Biomarkers in SchizophreniaCompletedNCT00817336Phase 2Results posted
- Safety and Effectiveness of D-serine in SchizophreniaCompletedNCT00322023Phase 2Results posted
- D-Serine Treatment of Negative Symptoms and Cognitive Deficits in SchizophreniaCompletedNCT00237809Phase 3Results posted
- D-serine AudRem: R33 PhaseSuspendedNCT05046353Phase 1/2
- D-serine Supplementation for DepressionCompletedNCT04721249Not applicable
- The Effect of D-serine as add-on Therapy in Recent-onset PsychosisTerminatedNCT04140773Not applicable
- D-Serine Treatment For Tardive DyskinesiaStatus unknownNCT01804920Not applicable
- D-Serine for Cocaine Dependence PilotWithdrawnNCT01715051Phase 2
- N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in SchizophreniaStatus unknownNCT01474395Phase 2
- High Dose D-Serine as Adjuvant Treatment for Recent Onset SchizophreniaStatus unknownNCT01459029Phase 2
- D-serine Monotherapy for SchizophreniaCompletedNCT00816894Phase 2
- Sarcosine or D-Serine Add-on Treatment for Chronic SchizophreniaCompletedNCT00491569Phase 2
- D-Serine for Enhancing Cognitive Retraining for the Treatment of SchizophreniaCompletedNCT00237848Phase 3
- D-Serine Monotherapy for SchizophreniaStatus unknownNCT00215917Phase 1/2
- D-serine Adjuvant Treatment for Parkinson's DiseaseCompletedNCT00215904Phase 4
- D-serine for Posttraumatic Stress Disorder TreatmentCompletedNCT00215878Phase 2
- Israel Multicenter D-Serine Study (IMSER) for the Treatment of SchizophreniaStatus unknownNCT00138775Phase 2